Considerations in the Care of Athletes With Type 1 Diabetes Mellitus

Type 1 diabetes mellitus is an autoimmune disease caused by affected individuals' autoimmune response to their own pancreatic beta-cell. It affects millions of people worldwide. Exercise has numerous health and social benefits for patients with type 1 diabetes mellitus; however, careful managem...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2022-02, Vol.14 (2), p.e22447-e22447
Main Authors: Pujalte, George, Alhumaidi, Hebah M, Ligaray, Kenneth Patrick L, Vomer, 2nd, Rock P, Israni, Krishna, Abadin, Andre A, Meek, Shon E
Format: Article
Language:English
Subjects:
Aerobics
Athletes
Blood pressure
Carbohydrates
Diabetes
Endocrinology/Diabetes/Metabolism
Energy resources
Exercise
Family/General Practice
Glucose monitoring
Hemoglobin
Hyperglycemia
Hypoglycemia
Insulin
Internal Medicine
Interval training
Lipids
Physical fitness
Physiology
Sports medicine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Type 1 diabetes mellitus is an autoimmune disease caused by affected individuals' autoimmune response to their own pancreatic beta-cell. It affects millions of people worldwide. Exercise has numerous health and social benefits for patients with type 1 diabetes mellitus; however, careful management of blood glucose is crucial to minimize the risk of hypoglycemia and hyperglycemia. Anaerobic and aerobic exercises cause different glycemic responses during and after exercise, each of which will affect athletes' ability to reach their target blood glucose ranges. The optimization of the patient's macronutrient consumption, especially carbohydrates, the dosage of basal and short-acting insulin, and the frequent monitoring of blood glucose, will enable athletes to perform at peak levels while reducing their risk of dysglycemia. Despite best efforts, hypoglycemia can occur. Recognition of symptoms and rapid treatment with either fast-acting carbohydrates or glucagon is important. Continuous glucose monitoring devices have become more widely used in preventing hypoglycemia.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.22447